2024 APR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on breast cancer. According to news reporting out of Tubingen, Germany, by ...
Greenwich LifeSciences announced Phase III trial FLAMINGO-01's initiation in Germany, evaluating immunotherapy GLSI-100 for breast cancer recurrence prevention. Greenwich LifeSciences, Inc. has ...
Despite a significant increase in women with unilateral breast cancer who received a bilateral mastectomy, this study found no survival benefit compared with other treatment options. Although removing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results